Healthcare, Pharmaceuticals and Biotech
Kroll helps organizations in the healthcare, pharmaceuticals and biotechnology sectors address complex business challenges related to governance, risk and transparency.
Pharmaceutical, healthcare, biotech and medical device companies face a challenging, competitive health landscape. Pricing pressures, scientific breakthroughs, expanding demand for healthcare access and emerging digital and analytic capabilities push companies to explore unconventional business models and build value-based customer relationships.
Underpinning these dynamics is the uncertainty created by a post-COVID-19 environment. The implications have been far-reaching and will likely impact the entire life science ecosystem. While companies need to be aware of the risks to their organization, Kroll understands the complexity of these challenges and works with clients worldwide to drive progress, navigate new opportunities and manage risk.
Our life sciences specialists bring practical, in-depth experience to healthcare and life sciences companies, including consumer health, medical devices, diagnostics and pharmaceuticals. We help our clients address their most pressing challenges in in the areas of valuation, expert services, investigations, cyber risk, corporate finance, security, restructuring, legal and business solutions, data analytics, due diligence and regulatory compliance.
Kroll recently spoke with intellectual property expert Alexandra Pygall, a partner at Stephenson Harwood LLP, on patent waivers for the COVID-19 vaccines. Watch this short video to learn more about how patent waivers play a role in the global distribution of vaccines and what it can mean for the future of the healthcare and pharmaceutical industries.
Kroll Life Sciences Webcast Series
Pharmaceutical, healthcare, biotech and medical device companies face a challenging, competitive health landscape. Pricing pressures, scientific breakthroughs, expanding demand for healthcare access and emerging digital and analytic capabilities push companies to explore unconventional business models and build value-based customer relationships. Kroll recently brought together our leading experts and industry leaders to share insights and trends on valuation, technology, intellectual property (IP), risk and regulation in a life sciences webcast series.
Watch Webcast Replay
Connect With Us
See all servicesStay Ahead with Kroll
Valuation of businesses, assets and alternative investments for financial reporting, tax and other purposes.
Incident response, digital forensics, breach notification, managed detection services, penetration testing, cyber assessments and advisory.
Compliance and Regulation
End-to-end governance, advisory and monitorship solutions to detect, mitigate and remediate security, legal, compliance and regulatory risk.
Corporate Finance and Restructuring
M&A advisory, restructuring and insolvency, debt advisory, strategic alternatives, transaction diligence and independent financial opinions.
Investigations and Disputes
World-wide expert services and tech-enabled advisory through all stages of diligence, forensic investigation, litigation, disputes and testimony.
Digital Technology Solutions
Enriching our professional services, our integrated software platform helps clients discover, quantify and manage risk in the corporate and private capital market ecosystem.
Expert provider of complex administrative solutions for capital events globally. Our services include claims and noticing administration, debt restructuring and liability management services, agency and trustee services and more.
Environmental, Social and Governance
Advisory and technology solutions, including policies and procedures, screening and due diligence, disclosures and reporting and investigations, value creation, and monitoring.
Clop Ransomware Likely Sitting on MOVEit Transfer Vulnerability (CVE-2023-34362) Since 2021
Jun 08, 2023
by Scott Downie, Devon Ackerman, Laurie Iacono, Dan Cox
Responding to the Critical MOVEit Transfer Vulnerability (CVE-2023-34362)
Jun 07, 2023
by Scott Downie, Devon Ackerman, George Glass, Dave Truman
European Chemicals Update Report – Spring 2023
Jun 05, 2023
by Andreas Stoecklin, Philipp Bose, Javier Zoido, Jacques Giard, David Althoff, Stephen Burt, David Lu, Katsumi Asai , Howard Johnson, Alexandre Pierantoni, Paul Teuten, Dafydd Evans
Industry Multiples in India Report 2023 – 20th Edition
Jun 01, 2023
by Umakanta Panigrahi, Aviral Jain, Sanjay Ray
Kroll Strengthens Digital Forensics and Incident Response Team in EMEA with Colin Sheppard
May 25, 2023
Kroll Expands Valuation Advisory Services for Renewable Energy with Two Industry Specialists in Tax Equity and Cost Segregation
May 24, 2023
Mahmoud Totonji Joins Kroll as Managing Director for Saudi Arabia
May 17, 2023
Kroll Responder Recognized in 2023 Gartner Market Guide for Managed Detection and Response Services for the Third Consecutive Year
Mar 23, 2023
Fraud and Financial Crime Report 2023 Breakfast Briefing
Jul 05, 2023 - Join us for a breakfast discussion, led by our financial crime experts who will dive into the Fraud and Financial Crime Report 2023 survey insights and explore the tools and strategies you need to stay compliant and minimize your risk.
2023 State of Cyber Defense: The False-Positive of Trust – Virtual Briefing
Jun 28, 2023
Kroll at Infosecurity Europe 2023
Jun 20, 2023 - Join Kroll cyber risk experts at Infosecurity Europe in London June 20-22. Stop by stand R70 to catch the latest trends from the cyber frontlines.
Kroll to Exhibit at the Airmic Conference
Jun 19, 2023